Parallel Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
BCM
TWM
FGA
CWG
EFG
PFA
APA
Parallel Advisors's BTAL Position: Q1 2023 in Review
Parallel Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 350 shares — an estimated $7.42K sold.
Parallel Advisors first reported a position in BTAL in Q4 2018 and held it in 15 quarters. The position peaked at $7.42K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.
- Parallel Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
- Parallel Advisors sold 350 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $7.42K.
- Parallel Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2018 and held it in 15 quarters.
- Parallel Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $7.42K in Q4 2022.
- 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.
Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.